[Metastatic involvement of the central nervous system in breast cancer: role of herceptin].
The metastatic involvement pattern of breast cancer has been changing in recent years and, in this sense, an increase in the incidence of metastatic involvement of the central nervous system (CNS) is being observed. In this situation, the role that the introduction of new therapeutic agents has must still be defined. In this article, we review the possible role played by treatment with Herceptin in the appearance of metastatic involvements of the CNS.
Ocaña Fernández
A
A
Servicio de Oncología Médica, Hospital Universitario de Salamanca, Salamanca. aocana@vhebron.net
Navarro Martín
M
M
Cruz Hernández
J J
JJ
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000473:pathology*; D016543:Central Nervous System Neoplasms / Q000453:epidemiology / Q000209:etiology* / Q000556:secondary*; D005260:Female; D006801:Humans; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab